v3.25.2
Stockholders’ Equity - Schedule of Weighted-Average Assumptions (Details) - DiamiR Biosciences Corp. [Member]
12 Months Ended
May 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Expected term in years 10 years
Expected volatility 81.00%
Risk-free interest rate 4.10%
Expected dividend yield 0.00%